regulatory improvement and international standard compliance. The official assessment results, which would enhance the confidence of domestic and foreign investors, are expected in mid-2019. For the next three
firms demonstrated an improvement vis-à-vis the results from the previous inspection cycle. Such improvement was undoubtedly enabled by the formulation of audit firms’ root cause analysis process and
อร์ตี้ จำกัด (มหาชน) กรุณาระบุเงื่อนไขในการค้นหา ค้นหาบริษัท JP: JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED JSP: บริษัท เจ. เอส. พี. พร็อพเพอร์ตี้ จำกัด (มหาชน) ล้างเงื่อนไข
transportation costs, food quality improvement, as a result of profit margin in 2017 totalled Baht 933.44 million dropped from 2016 amount of Baht 120.66 million or 11.45% and gross profit margin decreased from
sales has marginally improved, resulting to the decrease from 23.18% in previous year to 22.75%. This decrease was due to the improvement in cost efficiency. 4. Finance cost was Baht 98.07 million, a
million or increase 396.0%, due to production efficiency improvement and gain from sale on flexible packaging 3. Selling expenses In Q1/2018, the selling expenses was Baht 2.63 million compare with the same
were the investment for machine and equipment improvement as well as an addition investment of machine and equipment in Jiangsu Plant. Inventories increased Baht 39.38 million in order to support order
improvement. Other Transaction In Year 2018, the company recorded Baht 34.0 million from gain on changes in fair value less costs to sell biological asset, gain on sales deposits from land Baht 22.2 million and
improvement in shipping costs and adjustment of commission policy which was adjusted to pay at lower rate than last year. 8. Administrative expenses In 2018, administrative expenses increased by Baht 20. 0
from sale of property, plant and equipment Baht 2.08 million - Cash paid for payable from purchase of building improvement and equipment Baht (16.74) million 3. Cash flow from financing activity, net